Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Rösner

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Opinion on Investigational Drugs|September 28, 2010
Nalmefene for treatment of alcohol dependenceMichael Soyka, Susanne Rösner
Current Drug Abuse Reviews|July 28, 2009
Opioid antagonists for pharmacological treatment of alcohol dependence - a critical reviewMichael Soyka, Susanne Rösner
CNS Drugs|June 27, 2019
Outcome Assessment in Trials of Pharmacological Treatments for Alcohol Use Disorders: Fair and Strict TestingSusanne Rösner, Michael Soyka
Der Nervenarzt|July 23, 2020
[Pharmacotherapy of alcohol withdrawal: update and new developments]Michael Soyka, Susanne Rösner
Expert Opinion on Emerging Drugs|June 22, 2010
Emerging drugs to treat alcoholismMichael Soyka, Susanne Rösner
Expert Opinion on Pharmacotherapy|December 20, 2024
Modern pharmacotherapy guidance for treating alcohol use disordersMichael Soyka, Susanne Rösner
The Cochrane Database of Systematic Reviews|November 29, 2018
Baclofen for alcohol use disorderSilvia Minozzi, Rosella Saulle, Susanne Rösner
Journal of Substance Abuse Treatment|March 12, 2022
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational studySmeralda Senn, Thomas Volken, Susanne Rösner, et al.
Journal of Psychopharmacology (Oxford, England)|January 12, 2008
Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomesSusanne Rösner, Stefan Leucht, Philippe Lehert, et al.
The Cochrane Database of Systematic Reviews|January 13, 2023
Baclofen for alcohol use disorderRoberta Agabio, Rosella Saulle, Susanne Rösner, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Investigational Drugs|September 28, 2010
Nalmefene for treatment of alcohol dependenceMichael Soyka, Susanne Rösner
Current Drug Abuse Reviews|July 28, 2009
Opioid antagonists for pharmacological treatment of alcohol dependence - a critical reviewMichael Soyka, Susanne Rösner
CNS Drugs|June 27, 2019
Outcome Assessment in Trials of Pharmacological Treatments for Alcohol Use Disorders: Fair and Strict TestingSusanne Rösner, Michael Soyka
Der Nervenarzt|July 23, 2020
[Pharmacotherapy of alcohol withdrawal: update and new developments]Michael Soyka, Susanne Rösner
Expert Opinion on Emerging Drugs|June 22, 2010
Emerging drugs to treat alcoholismMichael Soyka, Susanne Rösner
Expert Opinion on Pharmacotherapy|December 20, 2024
Modern pharmacotherapy guidance for treating alcohol use disordersMichael Soyka, Susanne Rösner
The Cochrane Database of Systematic Reviews|November 29, 2018
Baclofen for alcohol use disorderSilvia Minozzi, Rosella Saulle, Susanne Rösner
Journal of Substance Abuse Treatment|March 12, 2022
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational studySmeralda Senn, Thomas Volken, Susanne Rösner, et al.
Journal of Psychopharmacology (Oxford, England)|January 12, 2008
Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomesSusanne Rösner, Stefan Leucht, Philippe Lehert, et al.
The Cochrane Database of Systematic Reviews|January 13, 2023
Baclofen for alcohol use disorderRoberta Agabio, Rosella Saulle, Susanne Rösner, et al.
Pageof 3